SCHEMBL10595316

SCHEMBL10595316

Cc1cc(OCC(O)CNCCNC(=O)COCCO[N+](=O)[O-])c2cc(C)[nH]c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 3/20 0.38
▸ SLC6A2 P23975 2/20 0.38
▸ ABCB11 O95342 1/20 0.38
▸ ADRA2A P08913 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ OPRM1 P35372 1/20 0.38
▸ DRD3 P35462 1/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ LMNA P02545 2/20 0.35
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2D6 P10635 2/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ ADRB1 P08588 6/20 0.33
▸ ADRB2 P07550 6/20 0.33
▸ ADRB3 P13945 4/20 0.33
▸ MAPT P10636 3/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10504639 0.90 HTR1A (0.52) HTR1ASLC6A2ABCB11ADRA2APTGS1
SCHEMBL10503674 0.89 ABCB11 (0.38) HTR1ASLC6A2ABCB11ADRA2APTGS1
SCHEMBL10505008 0.89 ADRB3 (0.38) CYP3A4CYP2D6ADRB1ADRB2ADRB3
SCHEMBL10504503 0.88 HTR1A (0.37) HTR1ASLC6A2ABCB11ADRA2APTGS1
SCHEMBL10595244 0.82 KMT2A (0.41) KMT2AMEN1LMNACYP3A4CYP2D6
SCHEMBL10865205 0.82 ADRB1 (0.39) KMT2AMEN1ADRB1ADRB2ADRB3
SCHEMBL10864349 0.79 CYP3A4 (0.36) HTR1AKMT2AMEN1CYP3A4CYP2D6
SCHEMBL10594457 0.79 ADRB2 (0.36) KMT2AL3MBTL1ADRB1ADRB2ADRB3
SCHEMBL10503624 0.79 ADRB2 (0.52) HTR1ASLC6A2ABCB11ADRA2APTGS1
SCHEMBL10503386 0.78 ADRB1 (0.39) KMT2AMEN1ADRB1ADRB2ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4863949-A CARDIOVASCULAR DISORDER TREATMENT BOEHRINGER MANNHEIM GMBH (DE) 1989-09-05 — — US disclosed
EP-0200915-A1 Aminopropanol derivatives, process for their preparation, their use and medicines containing them Roche Diagnostics GmbH (DE) 1986-11-12 — — EP disclosed
Send feedback